Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chao, A.-S.
Right arrow Articles by Soong, Y.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chao, A.-S.
Right arrow Articles by Soong, Y.-K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 2, 311-313, February 2000
© 2000 European Society of Human Reproduction and Embryology

Successful treatment of recurrent pelvic desmoid tumour with tamoxifen: Case report

An-Shine Chao1,5, Chyong-Huey Lai1, Swei Hsueh2, Chih-Shou Chen3, Yuh-Cheng Yang4 and Yung-Kuei Soong1

1 Department of Obstetrics and Gynaecology, 2 Department of Pathology, 3 Department of Urology, Chang Gung Memorial Hospital, 5 Fu-Hsin Street, Tao-Yuan, and 4 Department of Obstetrics and Gynaecology, Mackay Memorial Hospital, Taiwan, ROC

The case report of a young woman with recurrent pelvic desmoid tumour successfully treated with tamoxifen is described. The desmoid tumour recurred within 6 months after the initial exploratory laparotomy. Tamoxifen therapy led to complete relief of ascites within 2 months and complete tumour regression by the end of the fourth month, and the patient has remained stable for 6 years. Without sacrificing pelvic organs or major vessels and preserving reproductive ability, tamoxifen should be considered as the first drug of choice in such a recurrent condition.

Key words: desmoid tumour/tamoxifen

5 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Obstet GynecolHome page
P. Klemi, K. Alanen, S. Hietanen, S. Grenman, M. Varpula, and T. Salmi
Response of Estrogen Receptor-Positive Intraabdominal Fibromatosis to Aromatase Inhibitor Therapy
Obstet. Gynecol., November 1, 2003; 102(5): 1155 - 1158.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.